Jabbour, E., Branford, S., Saglio, G., Jones, D., Cortes, J. E., & Kantarjian, H. M. (2010). Practical Advice for Determining the Role of BCR-ABL Mutations in Guiding Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia.
Citación estilo ChicagoJabbour, Elias, Susan Branford, Giuseppe Saglio, Dan Jones, Jorge E. Cortes, and Hagop M. Kantarjian. Practical Advice for Determining the Role of BCR-ABL Mutations in Guiding Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia. 2010.
Cita MLAJabbour, Elias, et al. Practical Advice for Determining the Role of BCR-ABL Mutations in Guiding Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia. 2010.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.